randomized [resa]
Trial [resa]
Transdermal [ftcn]
Continuous [idcn]
Combined [qlco]
Hormone [horm]
Replacement therapy [topp]
CARDIOVASCULAR [bdsy]
Markers, Risk [qlco]
Hormone replacement therapy [topp]
coronary heart disease [dsyn]
controversies [socb]
Continuous [idcn]
Combined [qlco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Benefits [qnco]
Coronary heart disease risk [inpr]
Marker [clna]
adverse effects [ftcn]
Seen [qlco]
Certain [qlco]
Hormone replacement therapy [topp]
regimens [inpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Aged [orga]
Entered [qlco]
prospective [resa]
DOUBLE BLIND [resa]
randomized [resa]
placebo [topp]
Controlled Clinical Trial [inpr]
Women [popg]
COMPLETED [qlco]
Study [mnob]
Women [popg]
Received [qlco]
Transdermal [ftcn]
Estradiol-17beta [horm, phsu, strd]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
Daily [tmco]
Identical [qlco]
placebo [topp]
Circulating [ftcn]
Marker [clna]
Vascular function [clna]
Forearm [bpoc]
Blood flow [orgf]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Glucose [bacs, carb, phsu]
Insulin [aapp, horm, phsu]
haemostatic [ortf]
Safety [hcpp]
Parameters [fndg]
Measured [qlco]
baseline [bodm]
treatment [ftcn]
Compared [acty]
placebo [topp]
months [tmco]
Hormone replacement therapy [topp]
Administration [ocac]
Decreased [qnco]
Selectin [aapp, bacs]
P NOS [aapp, imft]
Angiotensin Converting Enzyme [aapp, enzy, imft]
P NOS [aapp, imft]
Cholesterol [bacs, strd]
P NOS [aapp, imft]
Low-Density Lipoproteins [aapp, bacs, lipd]
P NOS [aapp, imft]
High density lipoprotein [aapp, bacs, lipd]
HDL3 [dsyn]
P NOS [aapp, imft]
Apolipoprotein AII [aapp, bacs]
P NOS [aapp, imft]
P NOS [aapp, imft]
Fasting [fndg]
Insulin [aapp, horm, phsu]
P NOS [aapp, imft]
Decreased [qnco]
Hormone replacement therapy [topp]
Group [idcn]
Factor VII Activity [lbpr]
Coagulation [ortf]
Decreased [qnco]
P NOS [aapp, imft]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Fibrin D-dimer [aapp, bacs]
Increased [qnco]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Group [idcn]
Prothrombin fragment 1+2 [aapp, bacs]
P NOS [aapp, imft]
Decreased [qnco]
placebo [topp]
Group [idcn]
Matrix Metalloproteinase 2 [aapp, enzy]
LDL Particle Size [lbpr]
Transdermal [ftcn]
Hormone replacement therapy [topp]
effects [qlco]
Vascular function [clna]
Coronary heart disease risk [inpr]
Marker [clna]
